Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 2, 2002, Pages 825-834

  Gentili, A ^a   Mulligan, T ^b   Godschalk, M ^c   Clore, J ^a   Patrie, J ^b   Iranmanesh, A ^b   Veldhuis, J D ^a,c  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; GROWTH HORMONE; SODIUM CHLORIDE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; TESTOSTERONE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; GROWTH HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; IMMUNORADIOMETRIC ASSAY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; TESTOSTERONE BLOOD LEVEL;

EID: 0036169278     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.2.8222     Document Type: Article

References (83)

1. Pituitary hormones and aging
2. Two-week pulsatile gonadotropin releasing hormone infusion unmasks dual (hypothalamic and Leydig-cell) defects in the healthy aging male gonadotropic axis
3. Attenuation of luteinizing hormone secretory burst amplitude is a proximate basis for the hypoandrogenism of healthy aging in men
4. Differential impact of age, sex-steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay
5. Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotropic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth-hormone-releasing-hormone (GHRH) pulsatile infusion
6. Low basal and persistent pulsatile growth hormone secretion are revealed in normal and hyposomatotropic men studied with a new ultrasensitive chemiluminescence assay
7. Endogenous growth hormone secretion and clearance rates in normal boys as determined by deconvolution analysis: Relationship to age, pubertal status and body mass
8. Pathophysiology of the neuroregulation of GH secretion in experimental animals and the human
9. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men
10. The effect of testosterone and estrogen on the pituitary growth hormone response to growth hormone releasing factor
11. Integrated concentrations of growth hormone correlated with plasma testoserone and bone age in preadolescent and adolescent males
12. Growth hormone secretion patterns in relation to LH and testosterone secretion throughout normal male puberty
13. Androgenic modulation of the growth hormone-IGF axis and its impact on metabolic outcomes
14. Growth hormone (GH) responsiveness to GHRH in normal adults is not affected by short-term gonadal blockade
15. Short-term modulation of the androgen milieu alters pulsatile but not exercise or GHRH-stimulated GH secretion in healthy men
16. The growth hormone-insulin-like growth factor I axis: Studies in man during growth
17. Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis
18. Testosterone deficiency in young men: Marked alterations in whole body protein kinetics, strength and adiposity
19. Clinical review 24: Androgens in the aging male
20. Age, disease, and changing sex hormone levels in middle-aged men: Results of the Massachusetts Male Aging study
21. Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: Progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor I to growth hormone
22. Impaired growth hormone secretion in the adult population: Relation to age and adiposity
23. Male hypothalamic-pituitary-gonadal axis
24. A liquid-phase immunoradiometric assay (IRMA) for human sex hormone binding globulin (SHBG)
25. Evaluation of an immunoassay for plasma sex hormone-binding globulin: Comparison with steroid-binding assay under physiological and pathological conditions
26. The pituitary gland secretes in bursts: Appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations
27. Deconvolution analysis of hormone data
28. Specific methodological approaches to selected contemporary issues in deconvolution analysis of pulsatile neuroendocrine data
29. Deconvohition analysis of neuroendocrine data: Waveform-specific and waveform-independent methods and applications
30. Amplitude modulation of a burst-like mode of cortisol secretion subserves the circadian glucocorticoid rhythm in man
31. Twenty-four hour rhythms in plasma concentrations of adenohypophyseal hormones are generated by distinct amplitude and/or frequency modulation of underlying pituitary secretory bursts
32. Older males secrete luteinizing hormone and testosterone more irregularly, and jointly more asynchronously, than younger males
33. Orderliness of hormone release patterns: A complementary measure to conventional pulsatile and circadian analyses
34. Hormone pulsatility discrimination via coarse and short time sampling
35. Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release
36. Approximate entropy as a measure of system complexity
37. Quantification of hormone pulsatility via an approximate entropy algorithm
38. Females secrete growth hormone with more process irregularity than males in both human and rat
39. Estrogen and testosterone, but not a non-aromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: Evidence from pubertal pathophysiology and sex-steroid hormone replacement
40. Gender and sexual maturation-dependent contrasts in the neuroregulation of growth-hormone (GH) secretion in prepubertal and late adolescent males and females
41. Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone
42. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness
43. Acute and chronic estrogen effects upon serum somatomedin activity, growth hormone, and prolactin in man
44. Interrelation of the therapeutic effects of growth hormone and testosterone on growth in hypopituitarism
45. Testosterone increases serum 1,25-dihydroxyvitamin D and insulin-like growth factor-1 in hypogonadal men
46. Effect of testosterone on growth hormone secretion in patients with anorchia and delayed puberty
47. Somatomedin response to testosterone stimulation in male pseudohermaphroditism, cryptorchidism, anorchia, or micropenis
48. Androgen-stimulated pubertal growth: The effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty
49. Growth hormone secretion enhanced by androgens
50. Sex steroids, growth hormone, IGF-I: Neuroendocrine and metabolic regulation in puberty
51. The effect of sex steroids on radioimmunoassayable plasma somatomedin C concentrations
52. Effect of testosterone on somatomedin-C concentrations in prepubertal boys
53. Physiologic testosterone or estradiol induction of puberty increases plasma somatomedin C
54. The effect of one-year cross-sex hormonal treatment on bone metabolism and serum insulin-like growth factor-1 in transsexuals
55. Actions of estrogen on the pulsatile, nyctohemeral, and entropic modes of growth hormone secretion
56. Proposed mechanisms of sex-steroid hormone neuromodulation of the human GH-IGF-I axis
57. Increased pulsatile, but not basal, growth hormone secretion rates and plasma insulin-like growth factor 1 levels during the preovulatory interval in normal women
58. Interaction between testosterone and growth hormone replacement therapy
59. The effect of testosterone and dihydrotestosterone on hypothalamic regulation of growth hormone secretion
60. Neuroendocrine control of pulsatile growth-hormone release in the human: Relationship with gender
61. Androgen receptor blockade with flutamide enhances growth hormone secretion in late pubertal males: Evidence for independent actions of estrogen and androgen
62. The effects of oxandrolone on the growth hormone and gonadal axes in boys with constitutional delay of growth and puberty
63. Growth hormone secretory dynamics during puberty
64. Estrogen receptors in the regulation of skeletal maturation and the GH/IGF-I axis in male mice
65. Estrogen receptors (ER) alpha, but not ER beta, gene is expressed in growth hormone-releasing hormone neurons of the male rat hypothalamus
66. Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2 driven GH secretion in postmenopausal women
67. Tripartite neuroendocrine activation of the human growth-hormone (GH) axis in women by continuous 24-hour GH-releasing peptide (GHRP-2) infusion: Pulsatile, entropic, and nyctohemeral mechanisms
68. Synthetic somatostatin analog (octreotide) suppresses daytime growth hormone secretion equivalently in young and older men: Preserved pituitary responsiveness to somatostatin's inhibition in aging
69. Longitudinal changes in growth hormone secretory process irregularity assessed transpubertally in healthy boys
70. Secretory process regularity monitors neuroendocrine feedback and feedforward signaling strength in humans
71. Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin's dose-dependent inhibition of fasting growth-hormone (GH) secretion
72. A quantitative estimation of growth hormone secretion in normal man: Reproducibility and relation to sleep and time of day
73. Physiological role of somatostatin on growth hormone regulation in humans
74. Neuroendocrine control of growth hormone secretion
75. Acromegaly due to ectopic growth hormone (GH)-releasing hormone production: Dynamic studies of GH and ectopic GHRH secretion
76. Primary gonadal failure in men selectively amplifies the mass of follicle stimulating hormone (FSH) secreted per burst and increases the disorderliness of FSH release: Reversibility with testosterone replacement
77. Influence of age on pulsatile LH release and responsiveness of the gonadotrophs to sex hormone feedback in men
78. Recent insights into neuroendocrine mechanisms of aging of the human male hypothalamo-pituitary-gonadal axis
79. Contemporary aspects of discrete peak detection algorithms. 1. The paradigm of the luteinizing hormone pulse signal in men
80. Serum LH concentrations in hypogonadal men during transdermal testosterone replacement through scrotal skin: Further evidence that aging eahances testosterone negative feedback
81. The gonadotropin-suppression activity of androgen is increased in elderly men
82. Aging alters feedforward and feedback linkages between LH and testosterone in healthy men
83. Age-related changes in the feedback regulation of gonadotropin secretion by sex steroids in men